Cargando…
A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome
Metabolic syndrome is a pathological condition characterized by obesity, hyperglycemia, hypertension, elevated levels of triglycerides and low levels of high-density lipoprotein cholesterol that increase cardiovascular disease risk and type 2 diabetes. Although numerous predisposing genetic risk fac...
Autores principales: | Misselbeck, Karla, Parolo, Silvia, Lorenzini, Francesca, Savoca, Valeria, Leonardelli, Lorena, Bora, Pranami, Morine, Melissa J., Mione, Maria Caterina, Domenici, Enrico, Priami, Corrado |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861239/ https://www.ncbi.nlm.nih.gov/pubmed/31740673 http://dx.doi.org/10.1038/s41467-019-13208-z |
Ejemplares similares
-
Combined use of protein biomarkers and network analysis unveils deregulated regulatory circuits in Duchenne muscular dystrophy
por: Parolo, Silvia, et al.
Publicado: (2018) -
Single-cell-led drug repurposing for Alzheimer’s disease
por: Parolo, Silvia, et al.
Publicado: (2023) -
Literature Mining and Mechanistic Graphical Modelling to Improve mRNA Vaccine Platforms
por: Leonardelli, Lorena, et al.
Publicado: (2021) -
Computational Analysis of Cytokine Release Following Bispecific T-Cell Engager Therapy: Applications of a Logic-Based Model
por: Selvaggio, Gianluca, et al.
Publicado: (2022) -
The 5-formyltetrahydrofolate futile cycle reduces pathway stochasticity in an extended hybrid-stochastic model of folate-mediated one-carbon metabolism
por: Misselbeck, Karla, et al.
Publicado: (2019)